Zobrazeno 1 - 10
of 19
pro vyhledávání: ''
Autor:
Gerald W. Prager, Markus Kieler, Alexandra Kaider, Matthias Unseld, Daniela Bianconi, Johann Wojta, Svitlana Demyanets
Publikováno v:
Medical Oncology (Northwood, London, England)
Interleukin-33 (IL-33) and its “decoy” receptor soluble ST2 (sST2) are involved in the development of chronic inflammation and cancer. We explored IL-33 and sST2 as a potential prognostic marker in patients with metastatic and locally advanced pa
Autor:
Jürgen Fischer, Monika Serke, Martin Wolf, Alexander Reuss, Niels Reinmuth, Cornelius Kortsik, Philipp A. Schnabel, Petra Neuser, Michael Thomas, Piotr Czapiewski, Matthias Villalobos, Stefan Andreas
Publikováno v:
Medical oncology (Northwood, London, England). 35(7)
Prior studies have demonstrated an association between excision repair cross-complementation group 1 (ERCC1) expression level and outcomes in patients with advanced non-small cell lung cancer (NSCLC) treated with platinum-based chemotherapy. The aim
Publikováno v:
Medical Oncology (Northwood, London, England)
In order to facilitate long-term treatment decisions, we aimed to define biomarkers defining the probability of receiving second-line (SL) targeted therapy (TT) in patients with metastatic renal cell carcinoma (mRCC) based on their characteristics pr
Publikováno v:
Medical oncology (Northwood, London, England). 33(11)
Oligometastasis is defined as a transitional state between localized and widespread systemic metastatic cancers. In colorectal cancer, the prognostic factors and prognostic value of preoperative serum carbohydrate antigen 19-9 (CA19-9) and carcinoemb
Publikováno v:
Medical oncology (Northwood, London, England). 31(12)
Malignant pleural mesothelioma (MPM) is a neoplastic disease with a poor prognosis. The complete resection of tumor with extra-pleural pneumonectomy is effective only for early stage epithelioid-type MPM. An accurate pathological diagnosis including
Autor:
Xinke Zhang, Xing Li, Jiehua He, Jun Tang, Jin Wang, Mingtian Yang, Hailin Tang, Xiaoming Xie
Publikováno v:
Medical oncology (Northwood, London, England). 31(9)
Primary squamous cell carcinoma of the breast (PSCCB) is an extremely rare breast tumor lacking hormone receptors and HER2 expression. However, in comparison with triple-negative invasive ductal carcinoma (TN-IDC), little is known about the PSCCB. Tw
Publikováno v:
Medical oncology (Northwood, London, England). 31(12)
Previous studies have established the role of phosphorylated form of insulin-like growth factor type 1 receptor (p-IGF1R) as a good candidate for tumor biomarker. The aims of this study were to investigate p-IGF1R expression status in gastric cancer
Publikováno v:
Medical oncology (Northwood, London, England). 31(8)
Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality in the world. We report that one oncogene amplified on chromosome 3q26, LMO1, a master transcriptional regulator of stemness, operates to drive strong growth phenotype in NSC
Publikováno v:
Medical oncology (Northwood, London, England). 31(10)
The purpose of this study was to assess the correlation of the pathologic complete response (pCR) and near-complete pathologic response (npCR) between gene expression profiling using either the dataset of 150 genes as determined by BluePrint/MammaPri
Publikováno v:
Medical oncology (Northwood, London, England). 30(4)
Hepatoma-derived growth factor (HDGF) has been verified to serve as a credible prognostic marker for several types of cancers, but its role in urologic carcinomas remains undetermined. In this study, we analyzed the significance of HDGF, as well as i